Skip to main content

Table 1 The clinicopathological features of all the studied patients

From: Clinical, pathological and prognostic implications of USP22, SIRT1 and E-cadherin expression in papillary thyroid cancer (PTC) and adjacent non-neoplastic tissue

 

No.

%

Age Group

 < 40y

18

45.0%

 ≥40y

22

55.0%

Sex

 M

11

26.8%

 F

29

74.3%

Histopathological subtype

 PTC conventional

36

45.0%

 PTC follicular variant

4

5.0%

 Adjacent non-neoplastic Thyroid tissue

40

50.0%

Group

 PTC

40

50.0%

 Adjacent non-neoplastic Thyroid tissue

40

50.0%